Show simple item record

dc.contributor.authorAnderson, Kristen
dc.contributor.authorFoster, Michele M
dc.contributor.authorFreeman, Christopher R
dc.contributor.authorScott, Ian A
dc.date.accessioned2018-05-08T01:04:33Z
dc.date.available2018-05-08T01:04:33Z
dc.date.issued2016
dc.identifier.issn0025-729X
dc.identifier.doi10.5694/mja16.00125
dc.identifier.urihttp://hdl.handle.net/10072/172929
dc.description.abstractAgoal of primary care research is to inform and facilitate beneficial change in health care delivery for both patients and clinicians in a way that is efficient for providers and economically sustainable for the health care system. Co-design or co-creation is a process whereby researchers and stakeholders jointly contribute to the ideation, planning, implementation and evaluation of new services and systems as a possible means to optimise the impact of research findings.1,2 Co-creation represents the highest form of stakeholder engagement, building on existing theories such as community-based participatory research,3 and emphasises the creation of value for both end users and researchers. However, it is often infeasible to co-create with all stakeholders at all stages of a research project. Decisions must be made about which stakeholders to involve at different stages to achieve the greatest return on investment for researchers’ and stakeholders’ time and contributions, considering the context in which change is likely to occur. In designing a controlled pilot study of a multifaceted intervention to reduce inappropriate polypharmacy in primary care involving 20 general practitioners and more than 150 patients in south-east Queensland, we identified both patients and prescribers as the most important stakeholders. For this project, however, we proposed that the critical gateway to effective co-creation in the first instance was the GP, with both the GP and patient to be involved in evaluating the pilot to inform future development. In this article, we describe the rationale for this approach, the process, challenge and value of cocreating with GPs in the planning and implementation of the intervention, and the anticipated value of involving both patients and GPs in the pilot’s evaluation.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherAustralasian Medical Publishing Company
dc.publisher.urihttps://www.mja.com.au/system/files/issues/204_07/10.5694mja16.00125.pdf
dc.relation.ispartofpagefromS41
dc.relation.ispartofpagetoS43
dc.relation.ispartofissue7
dc.relation.ispartofjournalMedical Journal of Australia
dc.relation.ispartofvolume204
dc.subject.fieldofresearchPublic Health and Health Services not elsewhere classified
dc.subject.fieldofresearchMedical and Health Sciences
dc.subject.fieldofresearchPsychology and Cognitive Sciences
dc.subject.fieldofresearchcode111799
dc.subject.fieldofresearchcode11
dc.subject.fieldofresearchcode17
dc.titleA multifaceted intervention to reduce inappropriate polypharmacy in primary care: research co-creation opportunities in a pilot study
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
dc.description.versionPublished
gro.rights.copyrightAnderson K, Foster MM, Freeman CR and Scott IA. A multifaceted intervention to reduce inappropriate polypharmacy in primary care: research co-creation opportunities in a pilot study. Med J Aust 2016; 204(7):S41-S44. © Copyright 2016 The Medical Journal of Australia – reproduced with permission.
gro.hasfulltextFull Text
gro.griffith.authorFoster, Michele M.


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record